IQV logo

IQVIA Holdings (IQV) Stock

Profile

Full Name:

IQVIA Holdings Inc.

Sector:

Healthcare

Country:

United States

IPO:

09 May 2013

Indexes:

Description:

IQVIA Holdings Inc. is a provider of advanced analytical, technological solutions and contract research services for the life sciences industry. The company was founded in 1982 as Quintiles IMS Holdings, Inc. and changed its name to its current one in November 2017. The corporate headquarters are located in Durham, North Carolina. The company's activities are carried out through three reporting segments: - Technologies and Analytics - solutions provide critical information, technological solutions, and services for clients in the life sciences industry. - Research and Development - provides services for clinical research and clinical trials for biopharmaceutical companies. - Contract Sales and Medical Solutions - provide contract sales for clients of biopharmaceutical products as well as for the broader healthcare market.

Key Details

Price

$201.30

Annual Revenue

$14.98 B(+3.98% YoY)

Annual EPS

$7.29(+27.45% YoY)

PE Ratio

26.42(-8.30% YoY)

Beta

1.04

Events Calendar

Earnings

Next earnings date:

Feb 06, 2025

Recent quarterly earnings:

Oct 31, 2024

Recent annual earnings:

Feb 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

21 Jan '25 Baird
Neutral
20 Dec '24 Stephens & Co.
Overweight
13 Dec '24 B of A Securities
Buy
12 Dec '24 Truist Securities
Buy
11 Dec '24 RBC Capital
Outperform
11 Dec '24 Baird
Neutral
04 Dec '24 RBC Capital
Outperform
19 Nov '24 Leerink Partners
Outperform
05 Nov '24 RBC Capital
Outperform
05 Nov '24 JP Morgan
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
IQV
businesswire.com21 January 2025

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will release its financial results for the fourth quarter and the entire year of 2024 before the market opens on Thursday, February 6, 2025. The management team will also hold a conference call and webcast at 9:00 a.m. Eastern Time on that day. You can find the earnings release and related financial details on the IQVIA Investor Relations website at http://ir.iqvia.com.

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
IQV
zacks.com17 January 2025

Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.

Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
IQV
zacks.com16 January 2025

The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.

Will IQVIA (IQV) Beat Estimates Again in Its Next Earnings Report?
Will IQVIA (IQV) Beat Estimates Again in Its Next Earnings Report?
Will IQVIA (IQV) Beat Estimates Again in Its Next Earnings Report?
IQV
zacks.com15 January 2025

IQVIA (IQV) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.

IQVIA Benefits From Global IT Infrastructure Amid Low Liquidity
IQVIA Benefits From Global IT Infrastructure Amid Low Liquidity
IQVIA Benefits From Global IT Infrastructure Amid Low Liquidity
IQV
zacks.com03 January 2025

The IQV stock benefits from a $330-billion market it can reach and a vast amount of data, which is what sets it apart.

IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains?
IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains?
IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains?
IQV
zacks.com23 December 2024

IQVIA (IQV) saw an increase in its share price during the last trading session, with higher-than-normal trading volume. However, the recent changes in earnings estimates for the stock do not indicate that it will continue to perform well in the future.

Why You Should Retain IQVIA Holdings Stock in Your Portfolio Now
Why You Should Retain IQVIA Holdings Stock in Your Portfolio Now
Why You Should Retain IQVIA Holdings Stock in Your Portfolio Now
IQV
zacks.com28 November 2024

IQV is recognized for its creative application of technology and data analysis.

Interpreting IQVIA (IQV) International Revenue Trends
Interpreting IQVIA (IQV) International Revenue Trends
Interpreting IQVIA (IQV) International Revenue Trends
IQV
zacks.com04 November 2024

Assess IQVIA's (IQV) dependence on revenue from international markets to gain insights into the company's financial health, growth potential, and possible stock price trends. This analysis can help determine how well the company might perform in the future.

IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y
IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y
IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y
IQV
zacks.com31 October 2024

The growth in IQV's revenue during the third quarter of 2024 is supported by strong performance in the Research and Development, as well as the Technology and Analytics areas.

IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates
IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates
IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates
IQV
zacks.com31 October 2024

IQVIA Holdings (IQV) reported quarterly earnings of $2.84 per share, which is higher than the Zacks Consensus Estimate of $2.81 per share. This is an increase compared to earnings of $2.49 per share from the same period last year.

FAQ

  • What is the primary business of IQVIA Holdings?
  • What is the ticker symbol for IQVIA Holdings?
  • Does IQVIA Holdings pay dividends?
  • What sector is IQVIA Holdings in?
  • What industry is IQVIA Holdings in?
  • What country is IQVIA Holdings based in?
  • When did IQVIA Holdings go public?
  • Is IQVIA Holdings in the S&P 500?
  • Is IQVIA Holdings in the NASDAQ 100?
  • Is IQVIA Holdings in the Dow Jones?
  • When was IQVIA Holdings's last earnings report?
  • When does IQVIA Holdings report earnings?
  • Should I buy IQVIA Holdings stock now?

What is the primary business of IQVIA Holdings?

IQVIA Holdings Inc. is a provider of advanced analytical, technological solutions and contract research services for the life sciences industry. The company was founded in 1982 as Quintiles IMS Holdings, Inc. and changed its name to its current one in November 2017. The corporate headquarters are located in Durham, North Carolina. The company's activities are carried out through three reporting segments: - Technologies and Analytics - solutions provide critical information, technological solutions, and services for clients in the life sciences industry. - Research and Development - provides services for clinical research and clinical trials for biopharmaceutical companies. - Contract Sales and Medical Solutions - provide contract sales for clients of biopharmaceutical products as well as for the broader healthcare market.

What is the ticker symbol for IQVIA Holdings?

The ticker symbol for IQVIA Holdings is NYSE:IQV

Does IQVIA Holdings pay dividends?

No, IQVIA Holdings does not pay dividends

What sector is IQVIA Holdings in?

IQVIA Holdings is in the Healthcare sector

What industry is IQVIA Holdings in?

IQVIA Holdings is in the Diagnostics & Research industry

What country is IQVIA Holdings based in?

IQVIA Holdings is headquartered in United States

When did IQVIA Holdings go public?

IQVIA Holdings's initial public offering (IPO) was on 09 May 2013

Is IQVIA Holdings in the S&P 500?

Yes, IQVIA Holdings is included in the S&P 500 index

Is IQVIA Holdings in the NASDAQ 100?

No, IQVIA Holdings is not included in the NASDAQ 100 index

Is IQVIA Holdings in the Dow Jones?

No, IQVIA Holdings is not included in the Dow Jones index

When was IQVIA Holdings's last earnings report?

IQVIA Holdings's most recent earnings report was on 31 October 2024

When does IQVIA Holdings report earnings?

The next expected earnings date for IQVIA Holdings is 6 February 2025

Should I buy IQVIA Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions